Abstract
Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there has been an increased interest towards providing focal therapy for patients with intermediate-risk disease. Focal therapy can act as a logical “middle ground” in patients who seek treatment while minimizing potential side effects of definitive whole-gland treatment. The aim of the current review is to define the rationale of focal therapy in patients with intermediate-risk prostate cancer and highlight the importance of patient selection in focal therapy candidacy.
Original language | English (US) |
---|---|
Pages (from-to) | 729-739 |
Number of pages | 11 |
Journal | World journal of urology |
Volume | 39 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2021 |
Keywords
- Focal therapy
- MRI
- prostate cancer
ASJC Scopus subject areas
- Urology